Literature DB >> 15953295

Psychometric properties of the HIT-6 among patients in a headache-specialty practice.

Ariane K Kawata1, Remy R Coeytaux, Robert F Devellis, Alan G Finkel, J Douglas Mann, Kevin Kahn.   

Abstract

OBJECTIVE: To evaluate the performance and score interpretability of the Headache Impact Test (HIT-6) questionnaire in a headache patient population.
BACKGROUND: The HIT-6 is a standardized questionnaire designed to assess headache-related disability. Norms have been established using randomly sampled respondents from the general population. This study evaluated the psychometric properties of the HIT-6 scale among new adult patients who presented for treatment at a university headache-specialty practice.
METHODS: Participants were 309 new patients who presented for treatment at a headache-specialty clinic in an academic medical center.
RESULTS: Respondents ranged in age from 18 to 91 years, with an average age of 41 years (SD = 13 years) and were predominantly female (77%). Over half (57%) experienced chronic daily headache. Scores ranged from 38 to 78, with an average of 65.6 (SD = 7.0) and the majority (87%) had "severe impact" (60 or higher). The scale showed high reliability (alpha= 0.87) and an exploratory factor analysis showed large loadings from |0.57| to |0.86| and suggested a single disability factor. Scores were moderately negatively correlated with Short Form Health Survey (SF-36) subscales, ranging from -0.22 for mental health to -0.57 for social functioning. Item response theory analyses showed that half of the items functioned well across the disability continuum, while the remaining items discriminated between low and high levels of headache impact.
CONCLUSIONS: These findings suggest that the HIT-6 is useful for assessing headache-related disability among patients who seek headache-specialty care.

Entities:  

Mesh:

Year:  2005        PMID: 15953295     DOI: 10.1111/j.1526-4610.2005.05130.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  26 in total

1.  Effect of Different Doses of Galcanezumab vs Placebo for Episodic Migraine Prevention: A Randomized Clinical Trial.

Authors:  Vladimir Skljarevski; Tina M Oakes; Qi Zhang; Margaret B Ferguson; James Martinez; Angelo Camporeale; Kirk W Johnson; Qiuling Shan; Jeffrey Carter; Aaron Schacht; Peter J Goadsby; David W Dodick
Journal:  JAMA Neurol       Date:  2018-02-01       Impact factor: 18.302

2.  Patient-Reported Outcome Measures in Sports Medicine: A Concise Resource for Clinicians and Researchers.

Authors:  Kenneth C Lam; Ashley N Marshall; Alison R Snyder Valier
Journal:  J Athl Train       Date:  2020-02-07       Impact factor: 2.860

3.  Service development or research: make sure you know which game you are playing.

Authors:  Jeremy Chataway; Ayesha Ali; Norma O' Flynn
Journal:  London J Prim Care (Abingdon)       Date:  2009

4.  Using disablement models and clinical outcomes assessment to enable evidence-based athletic training practice, part II: clinical outcomes assessment.

Authors:  Tamara C Valovich McLeod; Alison R Snyder; John T Parsons; R Curtis Bay; Lori A Michener; Eric L Sauers
Journal:  J Athl Train       Date:  2008 Jul-Aug       Impact factor: 2.860

5.  Migraine may be a risk factor for the development of complex regional pain syndrome.

Authors:  B L Peterlin; A L Rosso; S Nair; W B Young; R J Schwartzman
Journal:  Cephalalgia       Date:  2010-02       Impact factor: 6.292

6.  Reduction in the impact of chronic migraine with medication overuse after day-hospital withdrawal therapy.

Authors:  Susanna Usai; Licia Grazzi; Domenico D'Amico; Frank Andrasik; Gennaro Bussone
Journal:  Neurol Sci       Date:  2008-05       Impact factor: 3.307

7.  A novel way of functional retraining of cervical motor control in a water polo player with combined cervicogenic and tension type headaches.

Authors:  Marloes Thoomes-de Graaf; Erik Thoomes
Journal:  J Man Manip Ther       Date:  2016-02

8.  What Factors Contribute to Headache-Related Disability in Teens?

Authors:  Kathi J Kemper; Geoffrey Heyer; Ann Pakalnis; Philip F Binkley
Journal:  Pediatr Neurol       Date:  2015-12-24       Impact factor: 3.372

9.  Diet-induced changes in n-3- and n-6-derived endocannabinoids and reductions in headache pain and psychological distress.

Authors:  Christopher E Ramsden; Daisy Zamora; Alexandros Makriyannis; JodiAnne T Wood; J Douglas Mann; Keturah R Faurot; Beth A MacIntosh; Sharon F Majchrzak-Hong; Jacklyn R Gross; Amber B Courville; John M Davis; Joseph R Hibbeln
Journal:  J Pain       Date:  2015-05-07       Impact factor: 5.820

10.  Spinal postural variability relates to biopsychosocial variables in patients with cervicogenic headache.

Authors:  Sarah Mingels; Wim Dankaerts; Ludo van Etten; Liesbeth Bruckers; Marita Granitzer
Journal:  Sci Rep       Date:  2021-07-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.